KALA BIO, Inc.
KALA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001479419
No open-market purchases or sales by KALA BIO, Inc. insiders were filed in the last 90 days; 15 institutions reported holding it in 13F filings for Q2 2026, worth $1.21M in total; no superinvestor holds it.
Q4 2023 vs. Q3 2023
How the institutions holding KALA BIO, Inc. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Q4 2023 | Change |
|---|---|---|---|
| Holders | 26 | 25 | −1 |
| Shares | 513.7K | 525.9K | +12.2K (+2.4%) |
| Value | $4.57M | $3.68M | −$890.9K (−19.5%) |
New holders (2)
Institutions that held KALA BIO, Inc. at the end of Q4 2023 but not at the end of Q3 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Renaissance Technologies LLC | 14,100 | $99.0K | 0.00% |
| Tower Research Capital LLC (TRC) | 4,357 | $30.5K | 0.00% |
Sold out (3)
Institutions that held KALA BIO, Inc. at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| Dimensional Fund Advisors LP | 12,092 | $107.6K |
| Parkside Financial Bank & Trust | 38 | $339 |
| Bank of New Hampshire | 1 | $9 |